• Citer

Durable clinical benefit with nivolumab plus ipilimumab in DNA mismatch repair-deficient/microsatellite instability-high metastatic colorectal cancer

par Overman, Michael James;Hill, Andrew;Sawyer, Michael M.B.;Hendlisz, Alain ;Neyns, Bart;Svrcek, Magali;Moss, Rebecca R.A.;Ledeine, Jean Marie;Cao, Alexander Z.A.;Kamble, Shital;Kopetz, Scott;Lonardi, Sara;André, Thierry;Wong, Ka Yeung Mark;Lenz, Heinz-Josef;Gelsomino, Fabio;Aglietta, Massimo;Morse, Michael M.A.;Van Cutsem, Eric;McDermott, Ray
Référence Journal of clinical oncology, 36, 8, page (773-779)
Publication Publié, 2018-03

Article révisé par les pairs

• Détails
• Contenu

Titre:	Durable clinical benefit with nivolumab plus ipilimumab in DNA mismatch repair-deficient/microsatellite instability-high metastatic colorectal cancer
Auteur:	Overman, Michael James; Hill, Andrew; Sawyer, Michael M.B.; Hendlisz, Alain; Neyns, Bart; Svrcek, Magali; Moss, Rebecca R.A.; Ledeine, Jean Marie; Cao, Alexander Z.A.; Kamble, Shital; Kopetz, Scott; Lonardi, Sara; André, Thierry; Wong, Ka Yeung Mark; Lenz, Heinz-Josef; Gelsomino, Fabio; Aglietta, Massimo; Morse, Michael M.A.; Van Cutsem, Eric; McDermott, Ray
Informations sur la publication:	Journal of clinical oncology, 36, 8, page (773-779)
Statut de publication:	Publié, 2018-03
Sujet CREF:	Cancérologie
Note générale:	SCOPUS: ar.j
Langue:	Anglais
Identificateurs:	urn:issn:0732-183X
	info:doi/10.1200/JCO.2017.76.9901
	info:scp/85043396361